Page last updated: 2024-08-17

tetrabenazine and Alzheimer Disease

tetrabenazine has been researched along with Alzheimer Disease in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (16.67)18.2507
2000's3 (25.00)29.6817
2010's4 (33.33)24.3611
2020's3 (25.00)2.80

Authors

AuthorsStudies
Leitinger, G; Maurer, C; Radulović, S; Sunkara, S1
Choi, Y; Chung, SJ; Lee, PH; Lee, S; Lee, YH; Sohn, YH; Ye, BS; Yoo, H; Yun, M1
Adler, CH; Beach, TG; Belden, CM; Driver-Dunckley, E; Dugger, BN; Gupta, HV; Joshi, AD; Liebsack, C; Mehta, SH; Mintun, MA; Pontecorvo, MJ; Sabbagh, MN; Serrano, GE; Shill, HA; Siderowf, A; Sue, LI1
Adler, CH; Arora, A; Galasko, D; Joshi, AD; Liebsack, C; Lu, M; Mintun, MA; Pontecorvo, MJ; Sabbagh, MN; Shill, HA; Siderowf, A; Skovronsky, DM1
Barthel, H; Bullich, S; Catafau, AM; Ghetti, B; Hoffmann, A; Ironside, JW; Leverenz, J; Sabri, O; Schulz-Schaeffer, WJ; Seibyl, JP1
Frey, KA; Gilman, S; Junck, L; Koeppe, RA; Wernette, K1
Ackermann, U; Chételat, G; Drago, J; Gong, S; Jones, G; Kung, HF; Masters, CL; Mulligan, RS; O'Keefe, G; Okamura, N; Pejoska, S; Rowe, CC; Skovronsky, DM; Tochon-Danguy, H; Villemagne, VL1
Chételat, G; Drago, J; Jones, G; Kung, HF; Masters, CL; Mulligan, RS; O'Keefe, G; Okamura, N; Pejoska, S; Pontecorvo, M; Rowe, CC; Skovronsky, DM; Villemagne, VL1
An, H; Gilman, S; Giordani, B; Heumann, M; Junck, L; Koeppe, RA; Little, R; Persad, C; Wernette, K1
Albin, RL; Frey, KA; Gilman, S; Heumann, M; Joshi, A; Junck, L; Koeppe, RA; Little, R; Liu, S1
Agid, Y; Anglade, P; Brandel, JP; Duyckaerts, C; Hirsch, EC; Javoy-Agid, F; Lehéricy, S; Scherman, D; Villares, J1
Frey, KA; Kilbourn, MR; Wieland, DM1

Reviews

1 review(s) available for tetrabenazine and Alzheimer Disease

ArticleYear
Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders.
    International journal of molecular sciences, 2021, Nov-18, Volume: 22, Issue:22

    Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Brain; Humans; Huntington Disease; Levodopa; Memantine; Microscopy, Electron; Multiple Sclerosis; Neuronal Plasticity; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Parkinson Disease; Synapses; Synaptic Transmission; Tetrabenazine

2021

Other Studies

11 other study(ies) available for tetrabenazine and Alzheimer Disease

ArticleYear
Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
    Neurobiology of aging, 2020, Volume: 87

    Topics: Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine

2020
Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
    Journal of Alzheimer's disease : JAD, 2021, Volume: 80, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Dopamine; Ethylene Glycols; Fatal Outcome; Female; Fluorine Radioisotopes; Humans; Lewy Body Disease; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine

2021
PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.
    BMC neurology, 2014, Apr-09, Volume: 14

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Dopamine; Drug Combinations; Ethylene Glycols; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine

2014
Cerebellar Amyloid-β Plaques: How Frequent Are They, and Do They Influence 18F-Florbetaben SUV Ratios?
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:11

    Topics: Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Cerebellum; Female; Fluorine Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Male; Molecular Imaging; Organ Specificity; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tetrabenazine; Tissue Distribution

2016
Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2008, Volume: 4, Issue:1 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tetrabenazine

2008
In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.
    Archives of neurology, 2011, Volume: 68, Issue:7

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Area Under Curve; Brain Mapping; Female; Fluorine Radioisotopes; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; ROC Curve; Tetrabenazine; Vesicular Monoamine Transport Proteins

2011
Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging.
    Neuro-degenerative diseases, 2012, Volume: 10, Issue:1-4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amygdala; Aniline Compounds; Brain Mapping; Carbon Radioisotopes; Case-Control Studies; Corpus Striatum; Diagnosis, Differential; Female; Fluorine Radioisotopes; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Tetrabenazine; Thiazoles; Vesicular Monoamine Transport Proteins

2012
Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease.
    Annals of neurology, 2004, Volume: 55, Issue:6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Binding Sites; Biogenic Monoamines; Carbon Isotopes; Corpus Striatum; Female; Humans; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Presynaptic Terminals; Tetrabenazine; Tomography, Emission-Computed

2004
11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbon Radioisotopes; Cerebral Cortex; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; Regression Analysis; Tetrabenazine

2005
Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.
    Brain research, 1994, Oct-03, Volume: 659, Issue:1-2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autoradiography; Binding Sites; Biogenic Monoamines; Corpus Striatum; Female; Humans; Male; Middle Aged; Parkinson Disease; Reference Values; Tetrabenazine; Tritium

1994
Imaging of monoaminergic and cholinergic vesicular transporters in the brain.
    Advances in pharmacology (San Diego, Calif.), 1998, Volume: 42

    Topics: Acetylcholine; Alzheimer Disease; Brain; Carbon Radioisotopes; Carrier Proteins; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Neuromuscular Depolarizing Agents; Neurons; Neuropeptides; Neurotransmitter Agents; Parkinson Disease; Piperidines; Tetrabenazine; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tritium; Vesicular Acetylcholine Transport Proteins; Vesicular Biogenic Amine Transport Proteins; Vesicular Transport Proteins

1998